COVID-19: India one of the largest contributors of global solidarity trial, says WHO Chief Scientist, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

WHO Chief Scientist stressed that a pandemic requires multicountry and collaborative platform trials. “…an adaptive design where we bring on drugs to test…do it in very large sample size, an look at endpoints which are of public health importance like mortality,” she said., WHO Chief Scientist stressed that a pandemic requires multicountry and collaborative platform trials. “…an adaptive design where we bring on drugs to test…do it in very large sample size, an look at endpoints which are of public health importance like mortality,” she said., , Read More

Leave a Reply

Your email address will not be published.